Patients can’t wait, and neither will we

At Axovant, we operate with a sense of urgency to develop and deliver innovative gene therapies that transform the treatment of serious neurological and neuromuscular diseases. In this critical journey, we are inspired by breakthrough science and driven to challenge the status quo on behalf of patients and their families. By harnessing the transformative power of gene therapies, our aim is to fill their unmet medical needs with one-time therapies that deliver lifelong benefits.


Axovant is an agile organization with a sharp focus on the rapid delivery of lasting, transformative gene therapies. Our decision-making is guided by our compassion for patients and their urgent need for better solutions. To that end, we approach gene therapy development by selecting the product candidates that have great potential for transformative impact. We continue to tailor these therapies to precisely address the needs of the diseases and patients we serve. Our agile operations and leading manufacturing partnerships enable us to meet our goals for rapid clinical execution.


We have assembled a leadership team of the foremost experts in gene therapy development, manufacturing and commercialization. Our growing team is committed to answering the call of patients and has proven expertise in driving scientific breakthroughs into the clinic, navigating the regulatory environment, and ensuring patients have access to life-saving therapies. For us, every day matters because every life matters.


Eleven Times Square, 33rd Floor
New York, NY 10036
United States

+1-833-AXOVANT (1-833-296-8268)

  • Axovant Gene Therapies LinkedIn
  • Axovant Gene Therapies Twitter
  • Axovant Gene Therapies Facebook


Viaduktstrasse 8
4051 Basel